Sterling Capital Management’s Evolent Health EVH Stock Holding History

Sterling Capital Management’s Portfolio EVH Stock Details EVH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$6.25K	Sell	2,741 -2,304	-46%	-$7.31K	﹤0.01%	2621
2025 Q4	$20.2K	Sell	5,045 -139,363	-97%	-$775K	﹤0.01%	2222
2025 Q3	$1.22M	Buy	144,408 +42,115	+41%	+$409K	0.02%	571
2025 Q2	$1.15M	Buy	102,293 +2,112	+2%	+$19.4K	0.02%	576
2025 Q1	$949K	Sell	100,181 -6,163	-6%	-$62.3K	0.01%	631
2024 Q4	$1.2M	Buy	106,344 +28,424	+36%	+$500K	0.02%	588
2024 Q3	$2.2M	Buy	+77,920	New	+$2.01M	0.03%	361
2019 Q3	$1.68M	Buy	233,151 +48,347	+26%	+$347K	0.02%	456
2019 Q2	$1.47M	Buy	184,804 +38,458	+26%	+$455K	0.01%	471
2019 Q1	$1.84M	Buy	146,346 +26,721	+22%	+$423K	0.02%	415
2018 Q4	$2.39M	Buy	119,625 +7,161	+6%	+$166K	0.03%	346
2018 Q3	$3.19M	Hold	112,464	–	–	0.03%	318
2018 Q2	$2.37M	Buy	+112,464	New	+$2.13M	0.02%	371

Other funds holding EVH

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

CCM

Cadian Capital Management New York $821M AUM 14.36% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Rubicon Founders Nashville, Tennessee $138M AUM 61.96% 1-Year Est. Return

Engaged Capital Newport Beach, California $303M AUM 2.09% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

RSCM

Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Sterling Capital Management's EVH Position: Q1 2026 in Review

Sterling Capital Management reduced its Evolent Health (EVH) stake by 46% in Q1 2026, selling an estimated $7.31K and leaving 2,741 shares worth $6.25K. The position accounts for ﹤0.01% of the portfolio, ranked #2621.

Sterling Capital Management first reported a position in EVH in Q2 2018 and has held it in 13 quarters since. The position peaked at $3.19M in Q3 2018. 191 funds tracked by Wall St. Rank hold EVH as of Q1 2026.

Sterling Capital Management held 2,741 shares of Evolent Health worth $6.25K as of Q1 2026.
Sterling Capital Management sold 2,304 Evolent Health shares in Q1 2026, an estimated $7.31K.
Evolent Health made up ﹤0.01% of Sterling Capital Management's portfolio in Q1 2026, its #2621 holding.
Sterling Capital Management first reported a position in Evolent Health in Q2 2018 and has held it in 13 quarters since.
Sterling Capital Management's Evolent Health position peaked at $3.19M in Q3 2018.
191 funds tracked by Wall St. Rank held Evolent Health as of Q1 2026.

Based on Sterling Capital Management's 13F filing for Q1 2026, filed 22 Apr 2026.